James M. Randall

Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor–Based Immunotherapy

Yulian Khagi, Aaron M. Goodman, Gregory A. Daniels et al. · Clinical Cancer Research · 2017 · 202 citations · Full text

Medicine, Molecular Genetics, Oncology +17

A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma

Martin H. Voss, Arif Hussain, Nicholas J. Vogelzang et al. · Annals of Oncology · 2017 · 79 citations · Full text

Medicine, Oncology, Pharmacology +8

PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)

Rahul Aggarwal, Glenn Heller, David W. Hillman et al. · Journal of Clinical Oncology · 2024 · 49 citations · Full text

Medicine, Endocrinology, Oncology +17

Clinic-based depression screening in lung cancer patients using the PHQ-2 and PHQ-9 depression questionnaires: a pilot study

James M. Randall, Rochelle Voth, Erin H. Burnett et al. · Supportive Care in Cancer · 2013 · 30 citations

Medicine, Oncology, Psychiatry +15

Radiation Recall Pneumonitis After Treatment With Checkpoint Blockade Immunotherapy: A Case Series and Review of Literature

Paul Riviere, Whitney Sumner, M. Cornell et al. · Frontiers in Oncology · 2021 · 28 citations · Full text

Medicine, Oncology, Radiation Oncology +17